These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2908598)

  • 61. Target cell induced T cell activation with bispecific antibodies: a new concept for tumor immunotherapy.
    Wolf H; Freimann U; Jung G
    Recent Results Cancer Res; 1994; 135():185-95. PubMed ID: 8047693
    [No Abstract]   [Full Text] [Related]  

  • 62. Characterization of a murine monoclonal antibody specific for human early lymphohemopoietic cells.
    Malavasi F; Caligaris-Cappio F; Milanese C; Dellabona P; Richiardi P; Carbonara AO
    Hum Immunol; 1984 Jan; 9(1):9-20. PubMed ID: 6693298
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor therapy with monoclonal antibodies.
    Levy R; Miller RA
    Fed Proc; 1983 Jun; 42(9):2650-6. PubMed ID: 6343125
    [No Abstract]   [Full Text] [Related]  

  • 64. Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.
    Foon KA
    N Engl J Med; 1982 Sep; 307(11):686-7. PubMed ID: 6981064
    [No Abstract]   [Full Text] [Related]  

  • 65. [Use of monoclonal antibodies in hematology].
    Pagnucco G; Bernasconi C
    Riv Emoter Immunoematol; 1984; 31(1):1-35. PubMed ID: 6085185
    [No Abstract]   [Full Text] [Related]  

  • 66. Progress in the treatment of cutaneous T cell lymphomas with radiolabeled monoclonal antibodies.
    Rosen ST; Zimmer AM; Goldman-Leikin R; Kazikiewicz JM; Dykewicz MS; Silverstein EA; Spies SM; Kaplan EH
    Int J Rad Appl Instrum B; 1989; 16(6):667-8. PubMed ID: 2606722
    [No Abstract]   [Full Text] [Related]  

  • 67. From dendritic cells to tumour vaccines.
    Hamblin TJ
    Lancet; 1996 Mar; 347(9003):705-6. PubMed ID: 8601996
    [No Abstract]   [Full Text] [Related]  

  • 68. Treatment of B-cell and T-cell lymphomas with monoclonal antibodies.
    DiJulio JE
    Semin Oncol Nurs; 1988 May; 4(2):102-5. PubMed ID: 3287535
    [No Abstract]   [Full Text] [Related]  

  • 69. Derivatives of anti-idiotype antibodies in the treatment of B-cell lymphoma.
    Glennie MJ; Stevenson GT
    Adv Exp Med Biol; 1985; 186():843-53. PubMed ID: 3876727
    [No Abstract]   [Full Text] [Related]  

  • 70. A clinical trial of anti-idiotype therapy for B cell malignancy.
    Meeker TC; Lowder J; Maloney DG; Miller RA; Thielemans K; Warnke R; Levy R
    Blood; 1985 Jun; 65(6):1349-63. PubMed ID: 3888313
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A monoclonal antibody (B72.3) to adenocarcinoma of the colon and related tumors.
    Schlom J; Colcher D; Szpak CA; Johnston WW; Sugarbaker P; Carrasquillo JA; Reynolds JC; Larson SM
    Prog Clin Biol Res; 1989; 288():63-72. PubMed ID: 2717642
    [No Abstract]   [Full Text] [Related]  

  • 72. The role of CAMPATH-1 antibodies in the treatment of lymphoid malignancies.
    Dyer MJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):52-7. PubMed ID: 10561018
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Application of monoclonal antibodies to tumor diagnosis and therapy.
    Rosen ST; Winter JN; Epstein AL
    Ann Clin Lab Sci; 1983; 13(3):173-84. PubMed ID: 6347022
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Shared idiotypes expressed by human B-cell lymphomas.
    Miller RA; Hart S; Samoszuk M; Coulter C; Brown S; Czerwinski D; Kelkenberg J; Royston I; Levy R
    N Engl J Med; 1989 Sep; 321(13):851-7. PubMed ID: 2475779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. ILEX oncology acquires CD52 diagnostic rights for Campath.
    Expert Rev Mol Diagn; 2002 Nov; 2(6):525-6. PubMed ID: 12465444
    [No Abstract]   [Full Text] [Related]  

  • 76. Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice.
    Haseman MK; Goodwin DA; Meares CF; Kaminski MS; Wensel TG; McCall MJ; Levy R
    Eur J Nucl Med; 1986; 12(9):455-60. PubMed ID: 3102237
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of the idiotypic network in tumor immunity.
    Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
    J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Imaging and therapy of cancer with radiolabeled monoclonal antibodies.
    Goldenberg DM
    Prog Clin Biol Res; 1989; 288():413-27. PubMed ID: 2654957
    [No Abstract]   [Full Text] [Related]  

  • 79. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
    Buchmann I; Bunjes D; Kotzerke J; Martin H; Glatting G; Seitz U; Rattat D; Buck A; Döhner H; Reske SN
    Cancer Biother Radiopharm; 2002 Apr; 17(2):151-63. PubMed ID: 12030109
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Monoclonal antibodies in cancer therapy.
    Oldham RK
    J Clin Oncol; 1983 Sep; 1(9):582-90. PubMed ID: 6366145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.